Shibo Jiang Selected Research

HIV Infections (HIV Infection)

1/2020	Real-time imaging of individual virion-triggered cortical actin dynamics for human immunodeficiency virus entry into resting CD4 T cells.
10/2019	Rapid Elimination of Broadly Neutralizing Antibodies Correlates with Treatment Failure in the Acute Phase of Simian-Human Immunodeficiency Virus Infection.
1/2019	N-Substituted Pyrrole Derivative 12m Inhibits HIV-1 Entry by Targeting Gp41 of HIV-1 Envelope Glycoprotein.
7/2018	Combining New Non-Nucleoside Reverse Transcriptase Inhibitors (RTIs) with AZT Results in Strong Synergism against Multi-RTI-Resistant HIV-1 Strains.
1/2015	A Peptide Derived from the HIV-1 gp120 Coreceptor-Binding Region Promotes Formation of PAP248-286 Amyloid Fibrils to Enhance HIV-1 Infection.
3/2013	3-Hydroxyphthalic anhydride-modified human serum albumin as a microbicide candidate inhibits HIV infection by blocking viral entry.
1/2013	HIV-1 fusion is blocked through binding of GB Virus C E2-derived peptides to the HIV-1 gp41 disulfide loop [corrected].
12/2012	A bivalent recombinant protein inactivates HIV-1 by targeting the gp41 prehairpin fusion intermediate induced by CD4 D1D2 domains.
8/2002	Identification of inhibitors of the HIV-1 gp41 six-helix bundle formation from extracts of Chinese medicinal herbs Prunella vulgaris and Rhizoma cibotte.
1/2002	Peptide and non-peptide HIV fusion inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shibo Jiang Research Topics

Disease

183	Infections 04/2024 - 09/2002
38	COVID-19 04/2024 - 01/2020
32	Virus Diseases (Viral Diseases) 03/2024 - 03/2005
26	Human Influenza (Influenza) 03/2024 - 08/2006
21	Severe Acute Respiratory Syndrome 04/2022 - 09/2004
20	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 01/2002
10	HIV Infections (HIV Infection) 01/2020 - 01/2002
8	Influenza in Birds (Avian Flu) 06/2023 - 07/2010
8	Zika Virus Infection 01/2022 - 01/2017
8	Coronavirus Infections 01/2022 - 01/2015
6	Neoplasms (Cancer) 11/2022 - 02/2008
5	Communicable Diseases (Infectious Diseases) 02/2024 - 01/2017
5	Papillomavirus Infections 01/2023 - 06/2013
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2022 - 08/2015
4	Bites and Stings (Sting) 01/2023 - 01/2020
4	Lung Injury 11/2020 - 01/2014
3	Breakthrough Infections 11/2023 - 01/2022
3	Respiratory Syncytial Virus Infections 01/2021 - 01/2013
3	Inflammation (Inflammations) 01/2020 - 06/2012
3	Acute Lung Injury 04/2018 - 10/2011
2	Pneumonia (Pneumonitis) 01/2022 - 11/2020
2	Immune System Diseases (Immune Disorders) 11/2020 - 01/2017
2	Emerging Communicable Diseases (Emerging Infectious Diseases) 05/2020 - 03/2016
2	Poisoning 01/2018 - 10/2011
2	Hemorrhagic Fever with Renal Syndrome (HFRS) 09/2008 - 11/2002

Drug/Important Bio-Agent (IBA)

69	VaccinesIBA 02/2024 - 09/2004
68	Proteins (Proteins, Gene)FDA Link 04/2024 - 09/2004
52	Antiviral Agents (Antivirals)IBA 04/2024 - 09/2002
47	Peptides (Polypeptides)IBA 03/2024 - 01/2002
28	Neutralizing AntibodiesIBA 12/2023 - 09/2006
19	AntibodiesIBA 03/2024 - 11/2004
17	Monoclonal AntibodiesIBA 01/2022 - 11/2002
13	Anti-Infective Agents (Microbicides)IBA 01/2017 - 04/2002
11	Subunit VaccinesIBA 01/2022 - 01/2008
10	Immunoglobulin G (IgG)IBA 03/2024 - 12/2006
10	Glycoproteins (Glycoprotein)IBA 01/2022 - 04/2002
10	EpitopesIBA 10/2019 - 11/2002
9	Recombinant ProteinsIBA 04/2024 - 09/2008
9	Amyloid (Amyloid Fibrils)IBA 03/2024 - 11/2012
9	HIV Fusion InhibitorsIBA 01/2022 - 01/2002
8	Enfuvirtide (Fuzeon)FDA Link 08/2015 - 01/2004
7	Immune Sera (Antisera)IBA 11/2020 - 09/2004
6	Broadly Neutralizing AntibodiesIBA 01/2023 - 01/2017
5	Influenza Vaccines (Influenza Vaccine)FDA Link 06/2023 - 07/2010
5	Human Serum Albumin FDA LinkGeneric 03/2022 - 03/2013
5	Anti-HIV Agents (AIDS Drugs)IBA 01/2022 - 01/2002
5	3-hydroxyphthalic anhydrideIBA 01/2022 - 04/2011
5	Hemagglutinins (Hemagglutinin)IBA 07/2020 - 06/2013
5	Reverse Transcriptase InhibitorsIBA 07/2018 - 01/2004
5	Protease Inhibitors (Protease Inhibitor)IBA 12/2012 - 01/2002
4	Amino Acids FDA Link 04/2024 - 09/2006
4	Polysaccharides (Glycans)IBA 04/2024 - 06/2005
4	Therapeutic UsesIBA 01/2023 - 10/2019
4	Nelfinavir (Viracept)FDA Link 11/2022 - 08/2015
4	Peptide Hydrolases (Proteases)FDA Link 04/2022 - 09/2005
4	CytokinesIBA 11/2020 - 06/2012
4	Complement System Proteins (Complement)IBA 04/2018 - 10/2011
3	Inactivated VaccinesIBA 11/2023 - 09/2008
3	Membrane Proteins (Integral Membrane Proteins)IBA 10/2023 - 08/2005
3	HIV Protease InhibitorsIBA 11/2022 - 08/2015
3	LipopeptidesIBA 04/2022 - 04/2020
3	CholesterolIBA 01/2022 - 06/2014
3	COVID-19 VaccinesIBA 01/2022 - 01/2021
3	Interleukin-6 (Interleukin 6)IBA 11/2020 - 06/2012
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 10/2020 - 08/2002
3	InterferonsIBA 01/2020 - 01/2014
3	NucleosidesIBA 07/2018 - 12/2010
3	Zidovudine (Retrovir)FDA LinkGeneric 07/2018 - 05/2005
3	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2017 - 01/2013
3	AntigensIBA 12/2016 - 09/2008
3	OvalbuminIBA 03/2013 - 09/2008
3	CD4 Antigens (CD4 Antigen)IBA 01/2013 - 09/2005
3	sifuvirtideIBA 02/2011 - 04/2008
2	EnzymesIBA 03/2024 - 07/2008
2	MF59 oil emulsionIBA 03/2024 - 03/2016
2	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2023 - 12/2022
2	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2022 - 01/2020
2	GossypolIBA 01/2022 - 11/2019
2	Lactoglobulins (beta-Lactoglobulin)FDA Link 01/2022 - 06/2013
2	Drug CombinationsIBA 01/2021 - 04/2019
2	Metformin (Glucophage)FDA LinkGeneric 04/2019 - 01/2017
2	Peptide FragmentsIBA 01/2018 - 10/2017
2	ParaquatIBA 01/2018 - 10/2011
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2018 - 01/2013
2	avian influenza A virus hemagglutininIBA 10/2017 - 10/2013
2	4Dm2mIBA 06/2017 - 05/2016
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 06/2012
2	ADS J1IBA 09/2015 - 05/2014
2	Palivizumab FDA Link 02/2015 - 01/2013
2	Maleic Anhydrides (Maleic Anhydride)IBA 02/2015 - 03/2013
2	piperidineIBA 05/2012 - 06/2011
2	Recombinant Fusion ProteinsIBA 01/2011 - 10/2010
2	IntegrasesIBA 09/2010 - 09/2005
2	Human immunodeficiency virus 1 reverse transcriptaseIBA 09/2010 - 05/2005
2	SARS-CoV spike glycoproteinIBA 01/2008 - 03/2004

Therapy/Procedure

51	Therapeutics 04/2023 - 04/2006
6	Highly Active Antiretroviral Therapy (HAART) 01/2022 - 05/2011
3	Salvage Therapy 07/2018 - 09/2014
2	Immunotherapy 01/2022 - 11/2002
2	Intranasal Administration 01/2022 - 02/2015